Immunotech Laboratories, Inc. (IMMB: Grey Market) | Immunotech Laboratories, Inc. Announces Successful Completion of Phase III Testing of the Patented Immune Therapeutic Vaccine -1 Eighty percent of the test subjects achieved non-detectable levels of v
(0)
(0)